IAS-01

 

Model: IAS-01

Category: Pharmaceutical

Exhibitor: IMMUNADD INC.

Booth No: M629

 

Characteristic

 

IAS-01 is a vaccine adjuvant system composed of two synthetic components, IA-05 and IA-41.
IA-05: A next-generation saponin-based adjuvant fully synthesized by ImmunAdd, designed to enhance stability and manufacturability, featuring well-defined structure, consistent quality, and sustainable sourcing.
IA-41: A synthetic Toll-like receptor (TLR) agonist designed to stimulate specific immune activities.
The design of IAS-01 balances functionality, scalability, and industrial applicability. ImmunAdd upholds rigorous research and product compliance standards.
Technical Features:
All main components of IAS-01 are synthetic materials. Compared to similar products using natural extracts, IAS-01 offers a more defined composition that effectively improves product quality consistency and safety.
Comprehensive immune modulation strategy: The systematic combination allows vaccine developers to more comprehensively adjust adjuvant configurations and evaluate vaccine efficacy according to target pathogens or antigen types.
IAS-01 has been applied in multiple vaccine technology collaborations under development, covering infectious diseases and novel immune product designs.
Collaboration Models:
Technology licensing or joint development projects
Preclinical development and early-stage comparative testing of products

 

Other Products

 

• 

  IA-05

 

 

 

Back